Literature DB >> 11342263

Oxidative changes in brain pyridine nucleotides and neuroprotection using nicotinamide.

L K Klaidman1, S K Mukherjee, J D Adams.   

Abstract

Pyridine nucleotides are critical during oxidative stress due to their roles in reductive reactions and energetics. The aim of the present study was to examine pyridine nucleotide changes in six brain regions of mice after an intracerebroventricular injection of the oxidative stress inducing agent, t-butyl hydroperoxide (t-BuOOH). A secondary aim was to investigate the correlation between NAD+ levels and DNA fragmentation. Here, we demonstrate that t-BuOOH induced a rapid oxidation of NADPH and a slow depletion of NAD+ in most brain regions. A slight increase in NADH also occurred in five brain regions. NAD+ depletion was associated with increased DNA fragmentation. This suggests the initiation of a death cascade involving poly(ADP-ribose) polymerase (PARP), NAD+, ATP depletion and consequent cell death in brain tissue. PARP activity was accelerated in some brain regions after 20 min of oxidative stress. To counteract oxidative stress induced toxicity, NAD+ levels were increased in the brain using an intraperitoneal injection of nicotinamide. A surplus of brain NAD+ prevented DNA fragmentation in some brain regions. Nicotinamide administration also resulted in higher brain NADH, NADP+ and NADPH levels in some regions. Their synthesis was further upregulated during oxidative stress. Nicotinamide as a precursor for NAD+ may provide a useful therapeutic strategy in the treatment of neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11342263     DOI: 10.1016/s0304-4165(00)00181-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  19 in total

Review 1.  Targeting WNT, protein kinase B, and mitochondrial membrane integrity to foster cellular survival in the nervous system.

Authors:  Z Z Chong; K Maiese
Journal:  Histol Histopathol       Date:  2004-04       Impact factor: 2.303

2.  Protective function of nicotinamide against ketamine-induced apoptotic neurodegeneration in the infant rat brain.

Authors:  Najeeb Ullah; Ikram Ullah; Hae Young Lee; Muhammad Imran Naseer; Park Moon Seok; Jawad Ahmed; Myeong Ok Kim
Journal:  J Mol Neurosci       Date:  2011-12-08       Impact factor: 3.444

3.  A reversible early oxidized redox state that precedes macromolecular ROS damage in aging nontransgenic and 3xTg-AD mouse neurons.

Authors:  Debolina Ghosh; Kelsey R LeVault; Aaron J Barnett; Gregory J Brewer
Journal:  J Neurosci       Date:  2012-04-25       Impact factor: 6.167

4.  Dual-energy precursor and nuclear erythroid-related factor 2 activator treatment additively improve redox glutathione levels and neuron survival in aging and Alzheimer mouse neurons upstream of reactive oxygen species.

Authors:  Debolina Ghosh; Kelsey R LeVault; Gregory J Brewer
Journal:  Neurobiol Aging       Date:  2013-08-15       Impact factor: 4.673

5.  NADH hyperoxidation correlates with enhanced susceptibility of aged rats to hypoxia.

Authors:  Kelley A Foster; Russell R Margraf; Dennis A Turner
Journal:  Neurobiol Aging       Date:  2006-12-20       Impact factor: 4.673

6.  Nicotinamide protects HCN2 cells from the free radical generating toxin, tertiary butylhydroperoxide (t-BuOOH).

Authors:  Manisha Sonee; Johanna R. Martens; Suman K. Mukherjee
Journal:  Neurotox Res       Date:  2002 Nov-Dec       Impact factor: 3.911

Review 7.  Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury.

Authors:  Katrina Owens; Ji H Park; Rosemary Schuh; Tibor Kristian
Journal:  Transl Stroke Res       Date:  2013-08-10       Impact factor: 6.829

Review 8.  Postischemic oxidative stress promotes mitochondrial metabolic failure in neurons and astrocytes.

Authors:  Gary Fiskum; Camelia A Danilov; Zara Mehrabian; Linda L Bambrick; Tibor Kristian; Mary C McKenna; Irene Hopkins; E M Richards; Robert E Rosenthal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

9.  Nicotinamide reduces hypoxic ischemic brain injury in the newborn rat.

Authors:  Yangzheng Feng; Ian A Paul; Michael H LeBlanc
Journal:  Brain Res Bull       Date:  2005-12-15       Impact factor: 4.077

10.  Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia.

Authors:  Ji H Park; Aaron Long; Katrina Owens; Tibor Kristian
Journal:  Neurobiol Dis       Date:  2016-07-15       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.